Objective: Treatment of patients with hemophilia starts at the age of about 7 months and consists of lifelong intravenous substitution of coagulation factor. Secure venous access is therefore of paramount importance for prevention of bleeding complications and survival. We report our experience with arteriovenous fistula (AVF) creation in very young infants as vascular access.
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Effects of Saphenous and Perforating
Objective: Venous leg ulcers can take several weeks or months to heal and typically present with repeated cycles of ulceration, healing, and recurrence that result in high treatment costs and have a negative impact on patients' quality of life. The multicomponent compression bandage system is still regarded as the "gold standard" to treat venous ulceration because previous randomized controlled trials failed to show improvement in ulcer healing rates by venous insufficiency surgical treatment despite a decrease in ulcer recurrence risk. This study was designed to investigate whether radiofrequency endovenous ablation of saphenous and perforating insufficient veins could increase venous ulcer healing rates.
Methods: We performed a prospective, controlled, randomized, open label trial at a single-center in Brazil. Participants had venous leg ulcer related to saphenous and perforating vein insufficiency with no sign of current or previous deep venous thrombosis. We randomly assigned participants to receive weekly changed two-layer compression bandage system alone or surgical radiofrequency ablation of insufficient saphenous and perforating veins before receiving the same compression system. Participants were stratified by ulcer duration (>6 months or <6 months) and ulcer area (>5 cm 2 or <5 cm 2 ). The primary end points were ulcer healing hazard ratio 6, 12, and 24 weeks after treatment started (ClinicalTrials.gov identifier: NCT03293836).
Results: From January 2015 to August 2017, there were 56 patients randomly allocated to two treatment groups: 29 to multicomponent compression bandage alone and 27 to combined surgical and compressive treatment. The study is still ongoing, and 24 patients have been under intervention. We have therefore considered for analysis 15 participants from the surgical group and 17 participants from the isolated compressive treatment group. There are no statistically significant differences between groups in ulcer healing rates after 6 weeks. However, after 12 weeks, 73% of surgically treated patients have their ulcers healed vs 65% of patients treated by compression alone (hazard ratio, 4.968; 95% confidence interval, 1.05323.42; P ¼ .043). After 24 weeks, ulcer healing rate differences are even more evident (100% vs 76%), with chance of healing more than six times greater for the surgical group (hazard ratio, 6.278; 95% confidence interval, 1.69323.28; P ¼ .006).
Conclusions: Until now, 12-and 24-week venous ulcer healing rates were significantly greater in participants treated by endovenous radiofrequency ablation of saphenous and perforating veins plus two-layer compressive bandages than in patients who were treated with compression alone. We expect this difference to be maintained until the end of the study.
Author Disclosures: A. W. Baptista-Sincos: Nothing to disclose; W. Campos: Nothing to disclose; E. da Silva: Nothing to disclose; N. De Luccia: Nothing to disclose; R. Porta: Nothing to disclose; P. Puech-Leão: Nothing to disclose; J. Puggina: Nothing to disclose; I. Rafael. Sincos: Medtronic: Consulting fees (eg, advisory boards). 
